Impact of a Pharmacist-anesthesiologist Collaboration During Anesthesia Consultation on Prevention of Perioperative Medication Errors of Patients in Programmed Surgery (PREVEMCA)

The investigators will evaluate the efficiency of a pharmacist-anesthesiologist collaboration in the anesthetic consultation in the prevention of medical errors perioperatively in patients undergoing scheduled surgery

Study Overview

• Status: Completed
• Conditions: Surgical Procedures, Operative
• Intervention / Treatment: Other: Pluridisciplinary consultation

• Study Type: Observational
• Enrollment (Actual): 378

Contacts and Locations

Study Locations

• France
  • Montpellier, France, 34090
    • CHU de Montpellier
  • Nîmes, France, 30029
    • CHU de Nimes
  • Toulouse, France
    • CHU de Toulouse

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (ADULT, OLDER_ADULT)
• Accepts Healthy Volunteers: N/A
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

Patients hospitalized for a programmed surgery in the service of urology or digestive surgery at the CHU Nimes or orthopedic surgery in the CHU Montpellier or Toulouse

Description

Inclusion Criteria:

• The patient must have given their free and informed consent
• The patient must be a member or beneficiary of a health insurance plan
• The patient has at least one chronic medication prescription (associated with a chronic illness)
• The patient is hospitalized for a programmed surgery in the service of urology or digestive surgery at the CHU Nimes or orthopedic surgery in the CHU Montpellier or Toulouse

Exclusion Criteria:

• The subject is participating in an interventional study, or is in a period of exclusion determined by a previous study
• The subject refuses to sign the consent
• It is impossible to give the subject informed information
• The patient is under safeguard of justice or state guardianship
• The patient is having ambulatory programmed surgery
• The patient has an anesthetic consultation in a different health establishment

Study Plan

How is the study designed?

Number of groups / cohorts

2

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Standard consultation
Pharmacist-anesthesiologist consultation	Other: Pluridisciplinary consultation; Pharmacist-anesthesiologist team will be present during the anesthetic consultation

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Time Frame
Rate of patients with at least one medication error for chronic treatment	48 hours post-admission

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Nature of medication error	According to REMED (Revue des Erreurs liées aux Médicaments Et Dispositifs médicaux) classification	48 hours post-admission
Rate of medication errors corrected		48 hours post-admission
Rate of prescriptions respecting the Société Française d'Anesthésie et de Réanimation recommendations		48 hours post-admission
Rate of corrected medication errors or major, critical or catastrophic severity according to HAS 2018		48 hours post-admission
Rate of patients whose usually prescribed medication at admission is not available for them in the evening following surgery		48 hours post-admission
Rate of medications not available on the establishment's therapeutic book and not brought by the patient		48 hours post-admission
Duration in hospital	Days	End of hospitalization (max 30 days)
Rate of delay or cancellation of surgery linked to preoperational medication error		End of study (13 months)

Collaborators and Investigators

• Sponsor: Centre Hospitalier Universitaire de Nīmes
• Investigators: Study Director: Géraldine Leguelinel-Blache, Chu Nimes

Study record dates

Study Major Dates

• Study Start (ACTUAL): February 25, 2020
• Primary Completion (ACTUAL): August 20, 2021
• Study Completion (ACTUAL): September 30, 2021

Study Registration Dates

• First Submitted: July 5, 2019
• First Submitted That Met QC Criteria: July 5, 2019
• First Posted (ACTUAL): July 9, 2019

Study Record Updates

• Last Update Posted (ACTUAL): March 18, 2022
• Last Update Submitted That Met QC Criteria: March 17, 2022
• Last Verified: March 1, 2022

More Information

Terms related to this study

• Other Study ID Numbers: PHRCI/2018/GL-01

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No